Business Description
China NT Pharma Group Co Ltd
NAICS : 325412
ISIN : KYG2114L1059
Compare
Compare
Traded in other countries / regions
01011.Hong Kong IPO Date
2011-04-20Description
China NT Pharma Group Co Ltd is a technology-based pharmaceutical company. It is engaged in research and development, production, and sale of private-label drugs, as well as the provision of pharmaceutical marketing and promotion services in China. It focused on the research, development, production, and sales of orthopedic, psychiatric, and oncology drugs. The company operates in a single segment of Proprietary product production and sales. The company earns the majority of its revenue from the domestic market. The Group's revenue from an external customer was derived solely from its operations in the PRC.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -1.03 | |||||
| Debt-to-Equity | -1.02 | |||||
| Debt-to-EBITDA | -13.19 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -13.01 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -69.1 | |||||
| 3-Year EPS without NRI Growth Rate | 53 | |||||
| 3-Year FCF Growth Rate | 140.2 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.8 | |||||
| 9-Day RSI | 49.08 | |||||
| 14-Day RSI | 46.21 | |||||
| 6-1 Month Momentum % | 15.91 | |||||
| 12-1 Month Momentum % | -71.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.02 | |||||
| Quick Ratio | 0.02 | |||||
| Days Inventory | 165.63 | |||||
| Days Sales Outstanding | 1100.62 | |||||
| Days Payable | 258.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11.5 | |||||
| Shareholder Yield % | 500.42 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 156.68 | |||||
| Operating Margin % | 169.11 | |||||
| Net Margin % | 309.03 | |||||
| FCF Margin % | -113.58 | |||||
| ROA % | -17.08 | |||||
| ROIC % | -4.86 | |||||
| 3-Year ROIIC % | -2.8 | |||||
| ROC (Joel Greenblatt) % | -7.81 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-Free-Cash-Flow | 0.79 | |||||
| Price-to-Operating-Cash-Flow | 0.79 | |||||
| EV-to-EBIT | -15.23 | |||||
| EV-to-EBITDA | -15.23 | |||||
| EV-to-Revenue | -8.96 | |||||
| EV-to-FCF | 7.94 | |||||
| Earnings Yield (Greenblatt) % | -6.57 | |||||
| FCF Yield % | 87.11 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
China NT Pharma Group Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | -48.606 | ||
| EPS (TTM) (HK$) | -0.764 | ||
| Beta | 0.49 | ||
| Volatility % | 113.83 | ||
| 14-Day RSI | 46.21 | ||
| 14-Day ATR (HK$) | 0.022539 | ||
| 20-Day SMA (HK$) | 0.2334 | ||
| 12-1 Month Momentum % | -71.02 | ||
| 52-Week Range (HK$) | 0.17 - 0.94 | ||
| Shares Outstanding (Mil) | 264.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
China NT Pharma Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
China NT Pharma Group Co Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
China NT Pharma Group Co Ltd Frequently Asked Questions
What is China NT Pharma Group Co Ltd(HKSE:01011)'s stock price today?
The current price of HKSE:01011 is HK$0.24. The 52 week high of HKSE:01011 is HK$0.94 and 52 week low is HK$0.17.
When is next earnings date of China NT Pharma Group Co Ltd(HKSE:01011)?
The next earnings date of China NT Pharma Group Co Ltd(HKSE:01011) is .
Does China NT Pharma Group Co Ltd(HKSE:01011) pay dividends? If so, how much?
China NT Pharma Group Co Ltd(HKSE:01011) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers